Increased nuclear factor-kappaB activation in colitis of interleukin-2-deficient mice

Fajun Yang, Willem J S De Villiers, Eun Y. Lee, Craig J. McClain, Gary W. Varilek

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Recent studies support nuclear factor-kappaB (NF-κB) as a critical transcription factor in inflammatory bowel disease. We examined NF-κB and its inhibitors, IκB-α and IκB-β, in the colitis of interleukin-2 deficient (IL-2(-/-)) mice at the ages of 5, 10, and 15 weeks and compared them with those of age-matched wild-type mice. Colon levels of nuclear NF-κB and mRNA for NF-κB responsive cytokines interleukin-1β and tumor necrosis factor-alpha were markedly increased in interleukin-2(-/-) mice. Colon interleukin-1β protein levels were significantly elevated, consistent with increased interleukin-1β mRNA, whereas tumor necrosis factor-alpha protein levels were either lower than those of the control group or did not differ. Protein levels of the immunomodulatory cytokine interleukin-10 were diminished. The NF-κB responsive IκB-α was also increased, mirroring NF-κB activation. In contrast, IκB-β levels did not differ from those of wild-type mice in the 5- and 10-week groups and were only mildly increased in the 15-week group. Serum amyloid A, an acute phase protein that also is NF-κB-responsive, was dramatically elevated in the serum of interleukin-2(-/-) mice and correlated with the severity of the colitis. These data support a role for NF-κB in the pathogenesis of intestinal inflammation in interleukin-2(-/-) mice. The measurement of NF-κB in colon tissue samples may provide a sensitive means of assessing the state of activation of the mucosal immune response, and serum amyloid A appears to be a reliable biochemical marker of disease activity.

Original languageEnglish (US)
Pages (from-to)378-385
Number of pages8
JournalJournal of Laboratory and Clinical Medicine
Volume134
Issue number4
DOIs
StatePublished - Oct 1999
Externally publishedYes

Fingerprint

Colitis
Interleukin-2
Chemical activation
Interleukin-1
Serum Amyloid A Protein
Colon
Tumor Necrosis Factor-alpha
Cytokines
Messenger RNA
Proteins
Acute-Phase Proteins
Mucosal Immunity
Interleukin-10
Inflammatory Bowel Diseases
Transcription Factors
Immune Sera
Tissue
Biomarkers
Inflammation
Control Groups

ASJC Scopus subject areas

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

Increased nuclear factor-kappaB activation in colitis of interleukin-2-deficient mice. / Yang, Fajun; De Villiers, Willem J S; Lee, Eun Y.; McClain, Craig J.; Varilek, Gary W.

In: Journal of Laboratory and Clinical Medicine, Vol. 134, No. 4, 10.1999, p. 378-385.

Research output: Contribution to journalArticle

Yang, Fajun ; De Villiers, Willem J S ; Lee, Eun Y. ; McClain, Craig J. ; Varilek, Gary W. / Increased nuclear factor-kappaB activation in colitis of interleukin-2-deficient mice. In: Journal of Laboratory and Clinical Medicine. 1999 ; Vol. 134, No. 4. pp. 378-385.
@article{f8303987c3074f6b950cc5482fb06aa4,
title = "Increased nuclear factor-kappaB activation in colitis of interleukin-2-deficient mice",
abstract = "Recent studies support nuclear factor-kappaB (NF-κB) as a critical transcription factor in inflammatory bowel disease. We examined NF-κB and its inhibitors, IκB-α and IκB-β, in the colitis of interleukin-2 deficient (IL-2(-/-)) mice at the ages of 5, 10, and 15 weeks and compared them with those of age-matched wild-type mice. Colon levels of nuclear NF-κB and mRNA for NF-κB responsive cytokines interleukin-1β and tumor necrosis factor-alpha were markedly increased in interleukin-2(-/-) mice. Colon interleukin-1β protein levels were significantly elevated, consistent with increased interleukin-1β mRNA, whereas tumor necrosis factor-alpha protein levels were either lower than those of the control group or did not differ. Protein levels of the immunomodulatory cytokine interleukin-10 were diminished. The NF-κB responsive IκB-α was also increased, mirroring NF-κB activation. In contrast, IκB-β levels did not differ from those of wild-type mice in the 5- and 10-week groups and were only mildly increased in the 15-week group. Serum amyloid A, an acute phase protein that also is NF-κB-responsive, was dramatically elevated in the serum of interleukin-2(-/-) mice and correlated with the severity of the colitis. These data support a role for NF-κB in the pathogenesis of intestinal inflammation in interleukin-2(-/-) mice. The measurement of NF-κB in colon tissue samples may provide a sensitive means of assessing the state of activation of the mucosal immune response, and serum amyloid A appears to be a reliable biochemical marker of disease activity.",
author = "Fajun Yang and {De Villiers}, {Willem J S} and Lee, {Eun Y.} and McClain, {Craig J.} and Varilek, {Gary W.}",
year = "1999",
month = "10",
doi = "10.1016/S0022-2143(99)90152-X",
language = "English (US)",
volume = "134",
pages = "378--385",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Increased nuclear factor-kappaB activation in colitis of interleukin-2-deficient mice

AU - Yang, Fajun

AU - De Villiers, Willem J S

AU - Lee, Eun Y.

AU - McClain, Craig J.

AU - Varilek, Gary W.

PY - 1999/10

Y1 - 1999/10

N2 - Recent studies support nuclear factor-kappaB (NF-κB) as a critical transcription factor in inflammatory bowel disease. We examined NF-κB and its inhibitors, IκB-α and IκB-β, in the colitis of interleukin-2 deficient (IL-2(-/-)) mice at the ages of 5, 10, and 15 weeks and compared them with those of age-matched wild-type mice. Colon levels of nuclear NF-κB and mRNA for NF-κB responsive cytokines interleukin-1β and tumor necrosis factor-alpha were markedly increased in interleukin-2(-/-) mice. Colon interleukin-1β protein levels were significantly elevated, consistent with increased interleukin-1β mRNA, whereas tumor necrosis factor-alpha protein levels were either lower than those of the control group or did not differ. Protein levels of the immunomodulatory cytokine interleukin-10 were diminished. The NF-κB responsive IκB-α was also increased, mirroring NF-κB activation. In contrast, IκB-β levels did not differ from those of wild-type mice in the 5- and 10-week groups and were only mildly increased in the 15-week group. Serum amyloid A, an acute phase protein that also is NF-κB-responsive, was dramatically elevated in the serum of interleukin-2(-/-) mice and correlated with the severity of the colitis. These data support a role for NF-κB in the pathogenesis of intestinal inflammation in interleukin-2(-/-) mice. The measurement of NF-κB in colon tissue samples may provide a sensitive means of assessing the state of activation of the mucosal immune response, and serum amyloid A appears to be a reliable biochemical marker of disease activity.

AB - Recent studies support nuclear factor-kappaB (NF-κB) as a critical transcription factor in inflammatory bowel disease. We examined NF-κB and its inhibitors, IκB-α and IκB-β, in the colitis of interleukin-2 deficient (IL-2(-/-)) mice at the ages of 5, 10, and 15 weeks and compared them with those of age-matched wild-type mice. Colon levels of nuclear NF-κB and mRNA for NF-κB responsive cytokines interleukin-1β and tumor necrosis factor-alpha were markedly increased in interleukin-2(-/-) mice. Colon interleukin-1β protein levels were significantly elevated, consistent with increased interleukin-1β mRNA, whereas tumor necrosis factor-alpha protein levels were either lower than those of the control group or did not differ. Protein levels of the immunomodulatory cytokine interleukin-10 were diminished. The NF-κB responsive IκB-α was also increased, mirroring NF-κB activation. In contrast, IκB-β levels did not differ from those of wild-type mice in the 5- and 10-week groups and were only mildly increased in the 15-week group. Serum amyloid A, an acute phase protein that also is NF-κB-responsive, was dramatically elevated in the serum of interleukin-2(-/-) mice and correlated with the severity of the colitis. These data support a role for NF-κB in the pathogenesis of intestinal inflammation in interleukin-2(-/-) mice. The measurement of NF-κB in colon tissue samples may provide a sensitive means of assessing the state of activation of the mucosal immune response, and serum amyloid A appears to be a reliable biochemical marker of disease activity.

UR - http://www.scopus.com/inward/record.url?scp=0033215369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033215369&partnerID=8YFLogxK

U2 - 10.1016/S0022-2143(99)90152-X

DO - 10.1016/S0022-2143(99)90152-X

M3 - Article

VL - 134

SP - 378

EP - 385

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 4

ER -